1. Protium spruceanum Extract Enhances Mupirocin Activity When Combined with Nanoemulsion-Based Hydrogel: A Multi-Target Strategy for Treating Skin and Soft Tissue Infections.
- Author
-
Amparo, Tatiane Roquete, Sousa, Lucas Resende Dutra, Xavier, Viviane Flores, Seibert, Janaína Brandão, Paiva, Débora Luiza, da Silva, Débora dos Santos, Teixeira, Luiz Fernando de Medeiros, dos Santos, Orlando David Henrique, Vieira, Paula Melo de Abreu, de Souza, Gustavo Henrique Bianco, and Brandão, Geraldo Célio
- Subjects
- *
MUPIROCIN , *SOFT tissue infections , *HYDROGELS , *DRUG resistance in bacteria , *MEMBRANE permeability (Biology) , *ANTIBACTERIAL agents , *SKIN permeability - Abstract
The treatment of skin and soft tissue infections (SSTIs) can be challenging due to bacterial resistance, particularly from strains like MRSA and biofilm formation. However, combining conventional antibiotics with natural products shows promise in treating SSTIs. The objective of this study is to develop a nanoemulsion-based hydrogel containing Protium spruceanum extract and mupirocin and evaluate its potential for the treatment of SSTIs. The nanoemulsion was obtained by phase inversion and subsequently characterized. The antibacterial activity was evaluated in vitro against S. aureus MRSA, including the synergism of the combination, changes in membrane permeability using flow cytometry, and the anti-biofilm effect. In addition, the irritative potential was evaluated by the HET-CAM assay. The combination exhibited synergistic antibacterial activity against S. aureus and MRSA due to the extract enhancing membrane permeability. The hydrogel demonstrated suitable physicochemical properties, inhibited biofilm formation, and exhibited low irritation. The formulation was nanometric (176.0 ± 1.656 nm) and monodisperse (polydispersity index 0.286 ± 0.011). It exhibited a controlled release profile at 48 h and high encapsulation efficacy (94.29 ± 4.54% for quercitrin and 94.20 ± 5.44% for mupirocin). Therefore, these findings suggest that the hydrogel developed could be a safe and effective option for treating SSTIs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF